Compare DRUG & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRUG | VHI |
|---|---|---|
| Founded | 2019 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 364.8M | 370.5M |
| IPO Year | N/A | N/A |
| Metric | DRUG | VHI |
|---|---|---|
| Price | $90.99 | $13.80 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 8 | 1 |
| Target Price | ★ $104.00 | $12.00 |
| AVG Volume (30 Days) | ★ 296.8K | 20.1K |
| Earning Date | 02-13-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 2.38% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.65 |
| Revenue | N/A | ★ $2,063,400,000.00 |
| Revenue This Year | N/A | $22.20 |
| Revenue Next Year | N/A | $7.66 |
| P/E Ratio | ★ N/A | $20.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.18 | $11.44 |
| 52 Week High | $123.75 | $25.25 |
| Indicator | DRUG | VHI |
|---|---|---|
| Relative Strength Index (RSI) | 59.47 | 61.81 |
| Support Level | $85.65 | $13.22 |
| Resistance Level | $92.00 | $14.11 |
| Average True Range (ATR) | 9.31 | 0.68 |
| MACD | 0.01 | 0.24 |
| Stochastic Oscillator | 37.59 | 95.34 |
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.